1. Home
  2. Companies
  3. Halozyme Therapeutics
  4. Financial Ratios
  5. DSO Ratio
Halozyme Therapeutics logo
Halozyme Therapeutics HALO
$ 71.48 1.06%

Quarterly report 2026-Q1
added 05-11-2026

report update icon

Halozyme Therapeutics DSO Ratio 2011-2026 | HALO

Annual DSO Ratio Halozyme Therapeutics

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
93.4 93.7 102 63.9 40.2 107 111 72.1 25.5 39 87.6 44.3 60.6 135 14.7 31.2 - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
135 14.7 70.1

Quarterly DSO Ratio Halozyme Therapeutics

2026-Q1 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
97.1 84.8 86.7 102 - 76 78 97.5 - 92 86 107 - 92.3 90.8 79.7 - 104 80.8 95.4 73.3 137 161 283 101 117 139 71.7 45.5 107 77.8 77 10.7 31.7 59.8 58.4 36.7 44.9 42.9 51.6 75.8 142 68.2 102 27.5 57.2 45.4 69.6 66.4 51.8 57.4 95.6 65.8 269 185 110 85.6 9 8.9 -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
283 8.9 86.7

DSO Ratio of other stocks in the Biotechnology industry

Issuer DSO Ratio Price % 24h Market Cap Country
FSD Pharma FSD Pharma
HUGE
 		2.94 K - 5743.5 % $ 69.7 M canadaCanada
Compugen Ltd. Compugen Ltd.
CGEN
 		400 $ 2.02 -0.98 % $ 189 M israelIsrael
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
 		29 - 1.35 % $ 17.8 M chinaChina
Coherus BioSciences Coherus BioSciences
CHRS
 		559 $ 1.42 - $ 166 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
 		186 - -10.17 % $ 12.2 K usaUSA
I-Mab I-Mab
IMAB
 		271 - - $ 866 M chinaChina
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
 		60.8 - - $ 2.18 B usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
 		84.7 - - $ 40.3 B usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
 		1.73 - - $ 2.17 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
 		13.6 - - $ 867 M germanyGermany
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
 		2.75 K - -1.52 % $ 24.7 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
 		204 - -18.52 % $ 27.3 M britainBritain
Affimed N.V. Affimed N.V.
AFMD
 		31.4 - -34.95 % $ 21.5 M germanyGermany
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
 		1.1 K $ 51.48 -0.23 % $ 4.63 B schweizSchweiz
Celyad Oncology SA Celyad Oncology SA
CYAD
 		64.4 - - $ 12.5 M belgiumBelgium
Berkeley Lights Berkeley Lights
BLI
 		103 - -7.31 % $ 87 M usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
 		321 $ 29.6 3.64 % $ 1.97 B usaUSA
Generation Bio Co. Generation Bio Co.
GBIO
 		47.6 - - $ 344 M usaUSA
IMV IMV
IMV
 		2.16 K - - $ 13.1 M canadaCanada
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
 		61.7 - - $ 7.46 M israelIsrael
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
 		3.66 K - -4.36 % $ 27 M usaUSA
Anika Therapeutics Anika Therapeutics
ANIK
 		76.5 $ 14.57 -0.21 % $ 209 M usaUSA
Advaxis Advaxis
ADXS
 		3.28 K - -9.65 % $ 45.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
 		146 - 5.93 % $ 314 M canadaCanada
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
 		216 - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
 		126 - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
 		17.9 - 1.93 % $ 17.4 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
 		28.1 $ 2.91 -5.52 % $ 4.79 M israelIsrael
Aptinyx Aptinyx
APTX
 		46.9 - -39.0 % $ 4.57 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
 		14.7 - -0.23 % $ 916 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
 		106 $ 22.79 5.8 % $ 2.9 B usaUSA